These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35057704)

  • 41. Design, synthesis, spectroscopic characterizations, single crystal X-ray analysis,
    Kaya G; Noma SAA; Barut Celepci D; Bayıl İ; Taskin-Tok T; Gök Y; Ateş B; Aktaş A; Aygün M; Tezcan B
    J Biomol Struct Dyn; 2023; 41(21):11728-11747. PubMed ID: 36622368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
    Bitew M; Desalegn T; Demissie TB; Belayneh A; Endale M; Eswaramoorthy R
    PLoS One; 2021; 16(12):e0260853. PubMed ID: 34890431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3-c]quinazolines as classical DNA intercalators.
    Alesawy MS; Ibrahim MK; Eissa IH; El-Adl K
    Arch Pharm (Weinheim); 2022 Apr; 355(4):e2100412. PubMed ID: 35014084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2'-Aryl and 4'-arylidene substituted pyrazolones: As potential α-amylase inhibitors.
    Yousuf S; Khan KM; Salar U; Chigurupati S; Muhammad MT; Wadood A; Aldubayan M; Vijayan V; Riaz M; Perveen S
    Eur J Med Chem; 2018 Nov; 159():47-58. PubMed ID: 30268823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New bis- and tetrakis-1,2,3-triazole derivatives: Synthesis, DNA cleavage, molecular docking, antimicrobial, antioxidant activity and acid dissociation constants.
    Nural Y; Ozdemir S; Yalcin MS; Demir B; Atabey H; Seferoglu Z; Ece A
    Bioorg Med Chem Lett; 2022 Jan; 55():128453. PubMed ID: 34801684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
    Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
    [No Abstract]   [Full Text] [Related]  

  • 47. Dihydropyrazole Derivatives Act as Potent α-Amylase Inhibitors and Free Radical Scavengers: Synthesis, Bioactivity Evaluation, Structure-Activity Relationship, ADMET, and Molecular Docking Studies.
    Ali A; Shah MIA; Fu C; Hussain Z; Qureshi MN; Farman S; Parveen Z; Zada A; Nayab S; Fazil P; Ateeq M; Rehman G; Naeem M; Ibrahim M; Khan M; Khan W
    ACS Omega; 2023 Jun; 8(23):20412-20422. PubMed ID: 37332823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of Thiazole-Chalcone Hybrid Molecules: Antioxidant, Alpha(α)-Amylase Inhibition and Docking Studies.
    Iqbal H; Akhtar T; Haroon M; Aktaş A; Tahir E; Ehsan M
    Chem Biodivers; 2023 May; 20(5):e202201134. PubMed ID: 37052518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bio-Potency and Molecular Docking Studies of Isolated Compounds from
    Ul Bari W; Ur Rehman N; Khan A; Ahsan Halim S; Yuan Y; Blaskovich MAT; Ziora ZM; Zahoor M; Naz S; Ullah R; Alotaibi A; Al-Harrasi A
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, biological activity and molecular modeling of a new series of condensed 1,2,4-triazoles.
    El Bakri Y; Marmouzi I; El Jemli M; Anouar EH; Karthikeyan S; Harmaoui A; Faouzi MEA; Mague JT; Essassi EM
    Bioorg Chem; 2019 Nov; 92():103193. PubMed ID: 31445196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, anticancer activity and molecular modeling study of novel substituted triazole linked tetrafluoronaphthalene hybrid derivatives.
    Erdoğan M; Comert Onder F
    J Biomol Struct Dyn; 2024 Nov; 42(18):9767-9786. PubMed ID: 37676264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic potential of
    Kikiowo B; Ogunleye JA; Iwaloye O; Ijatuyi TT
    J Biomol Struct Dyn; 2022 Mar; 40(4):1801-1812. PubMed ID: 33054572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-vitro anticancer evaluation of newly designed and characterized tri/tetra-substituted imidazole congeners- maternal embryonic leucine zipper kinase inhibitors: Molecular docking and MD simulation approaches.
    Mahapatra M; Mohapatra P; Pakeeraiah K; Bandaru RK; Ahmad I; Mal S; Dandela R; Sahoo SK; Patel H; Paidesetty SK
    Int J Biol Macromol; 2023 Sep; 249():126084. PubMed ID: 37532192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies.
    Yousuf H; Shamim S; Khan KM; Chigurupati S; Kanwal ; Hameed S; Khan MN; Taha M; Arfeen M
    Bioorg Chem; 2020 Mar; 96():103581. PubMed ID: 31978686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study.
    Allaka TR; Katari NK; Jonnalagadda SB; Malkhed V; Anireddy JS
    Curr Drug Discov Technol; 2021; 18(6):e130921187682. PubMed ID: 33155923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioevaluation of synthetic pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants.
    Saleem F; Khan KM; Ullah N; Özil M; Baltaş N; Hameed S; Salar U; Wadood A; Rehman AU; Kumar M; Taha M; Haider SM
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200400. PubMed ID: 36284484
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl ether derivatives, in vitro α-amylase inhibitory activity and in silico studies.
    Taha M; Imran S; Ismail NH; Selvaraj M; Rahim F; Chigurupati S; Ullah H; Khan F; Salar U; Javid MT; Vijayabalan S; Zaman K; Khan KM
    Bioorg Chem; 2017 Oct; 74():1-9. PubMed ID: 28719801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase.
    Abdelli I; Benariba N; Adjdir S; Fekhikher Z; Daoud I; Terki M; Benramdane H; Ghalem S
    J Biomol Struct Dyn; 2021 Feb; 39(3):816-822. PubMed ID: 31955660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, Synthesis, α-Amylase/α-Glucosidase Inhibition Assay, Induced Fit Docking Study of New Hybrid Compounds Containing 4H-Pyrano[2,3-d]pyrimidine, 1H-1,2,3-Triazole and D-Glucose Components.
    Toan VN; Thanh ND; Huyen LT; Hanh NT; Hai DS; Anh HH; Giang NTK; Van HTK
    Chem Biodivers; 2022 Dec; 19(12):e202200680. PubMed ID: 36408921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.